Patent classifications
G01N33/66
Self contained in-vitro diagnostic device
A portable apparatus for measuring a glucose level of a user having: a card-like member; a processor within the card-like member; at least one glucose sensor comprising a reagent, the glucose sensor generating a signal indicative of a measured glucose level upon application of a blood sample to the glucose sensor, wherein the glucose sensor is fixed to the card-like member and operably coupled to the processor; and at least one cover alterable between a first position in which the glucose sensor is covered and a second position in which the glucose sensor is exposed for use.
THERMOSTABLE GLUCOSE BIOSENSORS AND USES THEREOF
The present subject matter provides glucose biosensors as well as compositions, devices, and methods comprising such biosensors.
THERMOSTABLE GLUCOSE BIOSENSORS AND USES THEREOF
The present subject matter provides glucose biosensors as well as compositions, devices, and methods comprising such biosensors.
Biosensor using cell that expresses chemosensory receptor that can detect sugar, and alzheimer's disease diagnostic apparatus comprising same
The present invention relates to a biosensor that uses a cell that expresses a chemosensory receptor that can detect sugar, and an Alzheimer's disease diagnostic apparatus comprising the same. The biosensor and the Alzheimer's disease diagnostic apparatus of the present invention can sensitively detect a particular sugar in a sample, more inexpensively and more quickly, by fixing a drosophila cell having an over-expressed target sensory receptor protein on the cell surface through genetic engineering, and can thereby be efficaciously used for diagnosing Alzheimer's disease.
Biosensor using cell that expresses chemosensory receptor that can detect sugar, and alzheimer's disease diagnostic apparatus comprising same
The present invention relates to a biosensor that uses a cell that expresses a chemosensory receptor that can detect sugar, and an Alzheimer's disease diagnostic apparatus comprising the same. The biosensor and the Alzheimer's disease diagnostic apparatus of the present invention can sensitively detect a particular sugar in a sample, more inexpensively and more quickly, by fixing a drosophila cell having an over-expressed target sensory receptor protein on the cell surface through genetic engineering, and can thereby be efficaciously used for diagnosing Alzheimer's disease.
PORTABLE ELECTRONIC DEVICES AND SYSTEMS FOR ANALYZING AN ANALYTE
Some embodiments are directed to a portable electronic device for analyzing an analyte. The portable electronic device includes a housing, an adapter detachably coupled to the housing and a processor disposed in the housing. The adapter includes a body defining an opening for receiving a test strip and an interface port disposed within the body. The interface port is configured to read a signal from the test strip. The processor is communicably coupled to the interface port. The processor is configured to determine at least one parameter of the analyte based on the signal received from the interface port.
PORTABLE ELECTRONIC DEVICES AND SYSTEMS FOR ANALYZING AN ANALYTE
Some embodiments are directed to a portable electronic device for analyzing an analyte. The portable electronic device includes a housing, an adapter detachably coupled to the housing and a processor disposed in the housing. The adapter includes a body defining an opening for receiving a test strip and an interface port disposed within the body. The interface port is configured to read a signal from the test strip. The processor is communicably coupled to the interface port. The processor is configured to determine at least one parameter of the analyte based on the signal received from the interface port.
Hepatic insulin sensitizing substance and test meal for insulin sensitization
The present invention provides methods of treating prediabetes, hyperglycemia, type 2 diabetes, AMIS syndrome, and obesity in a subject by administering to the patient HISS. The present invention also provides methods of diagnosing AMIS syndrome in a patient. Additionally, the present invention provides a method of shifting nutrient storage in meat-producing livestock to muscle rather than fat.
Hepatic insulin sensitizing substance and test meal for insulin sensitization
The present invention provides methods of treating prediabetes, hyperglycemia, type 2 diabetes, AMIS syndrome, and obesity in a subject by administering to the patient HISS. The present invention also provides methods of diagnosing AMIS syndrome in a patient. Additionally, the present invention provides a method of shifting nutrient storage in meat-producing livestock to muscle rather than fat.
Pairing And Synchronizing A Mobile Phone Application With A Handheld Glucose Meter
A diabetes management system includes a handheld medical device, a mobile computing device, and a diabetes management application. The handheld medical device is configured to determine, in response to a port receiving a test strip, whether an auto-send feature is enabled on the handheld medical device, determine whether the handheld medical device is paired with a mobile computing device, and selectively instruct a wireless transceiver to establish a wireless connection and communicate a glucose measurement and identifying information to the mobile computing device. The mobile computing device is configured to execute the diabetes management application. The diabetes management application is configured to process a plurality of glucose measurements and identifying information associated with each of a plurality of glucose measurements.